37 results
DEFR14A
OCX
Oncocyte Corporation
22 May 23
Revised proxy
9:00am
percentiles in which executive compensation should fall so Oncocyte can be competitive in executive hiring and retention.
Report of the Audit Committee
8-K
EX-1.1
t8bnrv
19 Apr 22
Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants
4:01pm
8-K
EX-1.1
99fia
14 Jun 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
amuv ohthw
5 Feb 21
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
5:15pm
PRER14A
l6v fa5t6a
18 May 20
Preliminary revised proxy
6:06am
8-K
EX-10.1
ry3sl3m
20 Mar 20
Entry into a Material Definitive Agreement
4:30pm